Hecht G, Koutsouris A
Section of Digestive and Liver Diseases, Department of Medicine, University of Illinois and West Side Veterans Affairs Medical Center, Chicago, Illinois 60612, USA.
Am J Physiol. 1999 Sep;277(3):C441-7. doi: 10.1152/ajpcell.1999.277.3.C441.
The basally located actin cytoskeleton has been demonstrated previously to regulate Cl- secretion from intestinal epithelia via its effects on the Na+-K+-2Cl- cotransporter (NKCC1). In nontransporting epithelia, inhibition of myosin light chain kinase (MLCK) prevents cell-shrinkage-induced activation of NKCC1. The aim of this study was to investigate the role of myosin in the regulation of secretagogue-stimulated Cl- secretion in intestinal epithelia. The human intestinal epithelial cell line T84 was used for these studies. Prevention of myosin light chain phosphorylation with the MLCK inhibitor ML-9 or ML-7 and inhibition of myosin ATPase with butanedione monoxime (BDM) attenuated cAMP but not Ca2+-mediated Cl- secretion. Both ML-9 and BDM diminished cAMP activation of NKCC1. Neither apical Cl- channel activity, basolateral K+ channel activity, nor Na+-K+-ATPase were affected by these agents. Cytochalasin D prevented such attenuation. cAMP-induced rearrangement of basal actin microfilaments was prevented by both ML-9 and BDM. The phosphorylation of mosin light chain and subsequent contraction of basal actin-myosin bundles are crucial to the cAMP-driven activation of NKCC1 and subsequent apical Cl- efflux.
先前已证明,位于基底的肌动蛋白细胞骨架通过对钠-钾-2氯协同转运蛋白(NKCC1)的作用来调节肠道上皮细胞的氯离子分泌。在非转运上皮细胞中,抑制肌球蛋白轻链激酶(MLCK)可防止细胞收缩诱导的NKCC1激活。本研究的目的是探讨肌球蛋白在调节肠道上皮细胞中促分泌剂刺激的氯离子分泌中的作用。这些研究使用了人肠道上皮细胞系T84。用MLCK抑制剂ML-9或ML-7防止肌球蛋白轻链磷酸化,并用丁二酮单肟(BDM)抑制肌球蛋白ATP酶,可减弱cAMP介导而非Ca2+介导的氯离子分泌。ML-9和BDM均降低了NKCC1的cAMP激活。这些药物对顶端氯离子通道活性、基底外侧钾离子通道活性以及钠-钾-ATP酶均无影响。细胞松弛素D可防止这种减弱。ML-9和BDM均阻止了cAMP诱导的基底肌动蛋白微丝重排。肌球蛋白轻链的磷酸化以及随后基底肌动蛋白-肌球蛋白束的收缩对于cAMP驱动的NKCC1激活以及随后的顶端氯离子外流至关重要。